Navigation Links
Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology

line). Additionally, the percent of "responders" - those who had a 50 percent or greater reduction in seizure frequency - was significantly greater for the 900 and 1,200 mg groups than placebo (32 and 33 percent vs. 16 percent, respectively).

The double-blind study involved 73 centers in 19 countries (Europe, Australia and the United States), and included 396 patients who were 16 to 70 years of age with partial-onset seizures refractory to current treatment. After an initial 8-week baseline period, patients were randomly assigned to receive retigabine (600, 900 or 1,200 mg/day) or placebo, while maintaining their current therapies. Dosing of retigabine was increased gradually over a period of 8 weeks and then maintained for an additional 8 weeks.

It is currently estimated that 30 percent of those affected by epilepsy are not adequately controlled by existing medications. Retigabine is believed to act primarily by opening neuronal potassium-channels resulting in a hyperpolarizing shift that modulates the excitability of the neuronal cells. This mechanism of action (MOA) is different than other antiepileptic drugs.

Retigabine is an investigational compound that has not been found by the Food and Drug Administration (FDA) or any other regulatory agency to be safe or effective in the diagnosis, mitigation, treatment or cure of any disease or illness. It may not be sold or promoted in the United States unless and until the FDA has approved a New Drug Application. Similar restrictions apply in other countries.

About RESTORE

Retigabine is currently being investigated in the Retigabine Efficacy and Safety Trials for Partial Onset Epilepsy (RESTORE), two large, pivotal Phase 3 trials that will evaluate the safety and efficacy of retigabine in refractory epilepsy patients who are receiving one, two or three antiepileptic drugs (AEDs).

At the completion of these trials, retigabine will have been studied in more than 1,300 patients, mor
'"/>




Page: 1 2 3

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:5/17/2013)... May 17, 2013 The power of plants ... ways in which mankind depends on the plant kingdom, ... multifaceted exhibition Wild Medicine: Healing Plants ... on view from May 18 through September 8, 2013. ... The featured exhibition,s many attractions include a re-creation of ...
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... Mass., May 17, 2013   Shareholder rights attorneys ... Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a ... of Massachusetts .  The complaint alleges ... Securities Exchange Act of 1934 (the "Exchange Act") between ... Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
... YORK, Nov. 16, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0683626/X-ray-Equipment---Top-5-European-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... equipment analyses from the following European countries: ...
... Reportlinker.com announces that a new market ... X-ray Equipment - Top ... http://www.reportlinker.com/p0683628/X-ray-Equipment---Top-5-American-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging This package contains ... following American countries: United States, Mexico, Canada, ...
Cached Medicine Technology:X-ray Equipment - Top 5 European Markets 2X-ray Equipment - Top 5 American Markets 2
(Date:5/19/2013)... 2013 Dr. Keith Chertok now provides gum ... unhealthy gums and increase the chance of a healthier smile. ... Attachment Procedure (LANAP) not only removes diseased gum tissue in ... jaw bone for dental implants. , LANAP uses ... It can also help stimulate the healthy tissue as well ...
(Date:5/19/2013)... Exciting new Skin Brushes are available ... great practice known through the ages but is a ... body brushing, has so many benefits for our health ... "We love that circulation and lymphatic systems get a ... skin, is supported through Skin Brushing." , Why is ...
(Date:5/19/2013)... Beach, Florida (PRWEB) May 19, 2013 ... and market access, is pleased to unveil a new ... show environment that provides a powerful array of real-time ... partners in the US and abroad. , HE-Xpo is ... will offer attendees the look and feel of being ...
(Date:5/18/2013)... 19, 2013 In “Cooking with Spirits for ... , author Janet Hall Svisdahl’s new cookbook, readers are transported ... to make even the pickiest eater drool. “I dedicate this ... she explains. , Found within the 364 pages of ... of delicious recipes, from fast and simple to gourmet. Each ...
(Date:5/18/2013)... Los Angeles, California (PRWEB) May 18, 2013 ... band surgery is an increasingly popular weight loss surgery ... The Lap Band Center wishes to give ... technique. , Dr. Naim attended medical school at New ... residency at New York Methodist he undertook a fellowship ...
Breaking Medicine News(10 mins):Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3
... a handful of nutrient-rich dried plums each day help ... in postmenopausal women with osteoporosis or osteoarthritis?// - ... State University College of Human Sciences means to find ... is the principal investigator and a nationally recognized expert ...
... of Medicine have demonstrated the potential of a new ... cholesterol// levels. ,The findings are in the ... (NEJM). In this study, patients with homozygous familial hypercholesterolemia ... a remarkable 51% reduction in low-density lipoprotein (LDL) or ...
... of exercise is lethal for the liver, much more than ... characterized by collection of fat around the liver. The disease ... or cirrhosis or even cancer of the liver. ... clue to maintaining a healthy liver is to engage in ...
... published in the December 2006 issue of the Journal of ... Research Center at The Miriam Hospital and Brown Medical School, ... likely to skip breakfast and increase their fast food consumption ... gain. ,"Since the transition from adolescence to adulthood ...
... found to be deficient in nutrients or calories,// and may ... in the province, researchers from University of Ontario said. ... examined 180 food hampers, sourced from a well established food ... per cent of the hampers, meant to last three days, ...
... Jane Carlton of the New York University School of Medicine, ... The one-celled bacterium is the causal organism of ... and more severe among women. The infection is spread through ... ,In addition to causing uncomfortable itching in the genital ...
Cached Medicine News:Health News:Can Prunes Reverse Bone Loss After Menopause? 2Health News:Can Prunes Reverse Bone Loss After Menopause? 3Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 3Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 3
Using the patient's own blood pressure as the driving force, CAVR circulates cold blood through the Level 1 heat exchanger and returns it to the patient at body temperature for rapid core rewarming....
... HOTLINE can deliver normothermic fluid to your ... HOTLINE tubing design surrounds the patient line ... eliminating patient line cool down. The HOTLINE ... position, requires less priming volume, and is ...
... control panel is conveniently located on the swivel ... whether standing or sitting. The ventilator control panel ... numerics. The ventilator has CMV, PCV and SIME ... in two lengths facilitates both the placing of ...
... provides high quality ventilation and monitoring ... technologies of the AV2+ ventilator, breathing ... GS user-friendly and intuitive. , ... GS is the perfect introduction to ...
Medicine Products: